Filing Details

Accession Number:
0001562180-23-002106
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-02 09:53:47
Reporting Period:
2023-03-01
Accepted Time:
2023-03-02 09:53:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949870 Boston Beer Co Inc SAM Malt Beverages (2082) 043284048
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1393650 C John Geist C/O The Boston Beer Company, Inc.
One Design Center Place
Boston MA 02210
Chief Sales Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Acquisiton 2023-03-01 1,545 $0.00 6,219 No 4 A Direct
Class A Common Disposition 2023-03-01 646 $320.14 5,573 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common March 1, 2019 Stock Option Acquisiton 2023-03-01 637 $0.00 1,911 $312.56
Class A Common March 1, 2020 Stock Option Acquisiton 2023-03-01 628 $0.00 1,883 $370.79
Class A Common March 1, 2021 Stock Option Acquisiton 2023-03-01 208 $0.00 625 $1,028.71
Class A Common March 1, 2023 Stock Option Acquisiton 2023-03-01 3,084 $0.00 3,084 $323.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,911 2021-03-01 2029-02-28 No 4 A Direct
1,883 2022-03-01 2030-02-28 No 4 A Direct
625 2023-03-01 2031-02-28 No 4 A Direct
3,084 2025-03-01 2033-02-28 No 4 A Direct
Footnotes
  1. On March 1, 2023, the Issuer granted 1,545 RSUs to the Reporting Person under the Issuer's Employee Equity Incentive Plan ("EEIP"). The shares will vest in four equal installments over a four year period, provided that the Reporting Person remains employed by the Issuer on the applicable vesting dates, and subject to accelerated vesting in certain situations.
  2. The shares reported include 5,127 shares of restricted stock subject to vesting conditions. A total of 646 restricted shares vested on the Transaction Date.
  3. The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2019. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2020 over Fiscal Year 2018. In February 2021, the Compensation Committee determined that the performance criteria had been achieved, and as such the options vested in three equal installments on March 1 in the years 2021-2023.
  4. The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2020. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2021 over Fiscal Year 2019. In February 2022, the Compensation Committee determined that the performance criteria had been achieved, and as such the options vest in three equal installments on March 1 in the years 2022-2024, provided that the Reporting Person remains employed by the Company on the applicable vesting dates, and subject to accelerated vesting in certain situations.
  5. The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2021. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2022 over Fiscal Year 2020. In February 2023, the Compensation Committee determined that the performance criteria had been achieved, and as such the options vest in three equal installments on March 1 in the years 2023-2025, provided that the Reporting Person remains employed by the Company on the applicable vesting dates, and subject to accelerated vesting in certain situations.
  6. The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2023. The extent to which the options become exercisable is dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2024 over Fiscal Year 2022. The Compensation Committee will determine if the performance criteria have been achieved prior to March 1, 2025. If the performance criteria is achieved, the options vest in three equal installments on March 1 in the years 2025-2027, provided that the Reporting Person remains employed by the Company on the applicable vesting dates, and subject to accelerated vesting in certain situations.